
|Articles|December 4, 2016
Generic Drug Cost Concerns Highlight AJPB Week in Review
Author(s)Davy James, Managing Editor
Top articles of the week from The American Journal of Pharmacy Benefits.
Advertisement
Advertisement
Advertisement
Advertisement
Trending on Pharmacy Times
1
FDA Approves Apitegromab-mstn, First Muscle-Targeted SMA Therapy
2
Predictive Models Could Address Missing Data in Advanced Prostate Cancer
3
Ivonescimab Significantly Extends OS Over Pembrolizumab in PD-L1-Positive Advanced NSCLC
4
CGM and Ketone Data Reshape Pharmacist-Led Diabetes Care: Insights From NEIAP 2026
5




































































































